2Shepherd J,Blauw MB.Pravastatin in dderly individuals at risk of vascular disease(PROSPER):A randomised controlled trial[J].Lancet,2002,360:1623. 被引量：1
4BLUMENTHAL R S.Statins:effective antiatherosclerotic therapy[J].Am Heart,2000,139:577. 被引量：1
5Moron D J,Fazio S,Linton M F.Current perspectives on stains[J].Circulation,2000,102(2):207. 被引量：1
6谭毓治主编..药理学[M].北京:中国医药科技出版社,2006:407.
7Downs JR,Clearfield M,Weis S,et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels of AFCAPS/Tex CAPS[J].JAMA,1998,279(20):1615. 被引量：1
8Grundy S M.The issue of statin safety where do we stand[J].Circulation,2005,111:3016. 被引量：1
10Solovey A,Kollander R,Shet A,et al.Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygonation and inhibited by lovastatin[J].Blood,2004,104(3):840. 被引量：1
